Aditya Kohli Sells 6,000 Shares of HilleVax, Inc. (NASDAQ:HLVX) Stock

HilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli sold 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $14.73, for a total value of $88,380.00. Following the completion of the sale, the director now owns 764,878 shares in the company, valued at $11,266,652.94. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Aditya Kohli also recently made the following trade(s):

• On Monday, May 20th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $15.45, for a total value of $92,700.00.
• On Friday, May 3rd, Aditya Kohli sold 723 shares of HilleVax stock. The stock was sold at an average price of $14.15, for a total value of $10,230.45.
• On Wednesday, May 1st, Aditya Kohli sold 175 shares of HilleVax stock. The stock was sold at an average price of $14.03, for a total value of $2,455.25.
• On Friday, April 5th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $14.44, for a total value of $86,640.00.
• On Wednesday, April 3rd, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $14.93, for a total value of $89,580.00.
• On Wednesday, March 20th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $164,221.00, for a total value of $985,326,000.00.
• On Monday, March 18th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $17.66, for a total value of $105,960.00.
• On Friday, March 8th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $18.66, for a total value of $111,960.00.
• On Wednesday, March 6th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $18.95, for a total value of $113,700.00.
• On Thursday, February 22nd, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $15.05, for a total value of $90,300.00.

HilleVax Trading Down 2.7 %

HLVX stock traded down $0.39 during midday trading on Wednesday, reaching $14.14. The stock had a trading volume of 210,415 shares, compared to its average volume of 142,328. The business has a fifty day simple moving average of $14.65 and a two-hundred day simple moving average of $14.96. The company has a quick ratio of 10.92, a current ratio of 10.92 and a debt-to-equity ratio of 0.11. The firm has a market cap of $703.05 million, a price-to-earnings ratio of -4.28 and a beta of 0.79. HilleVax, Inc. has a twelve month low of $9.94 and a twelve month high of $20.22.

HilleVax (NASDAQ:HLVX) last posted its earnings results on Wednesday, March 20th. The company reported ($0.78) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.80) by $0.02. As a group, research analysts expect that HilleVax, Inc. will post -3.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on HLVX shares. HC Wainwright reiterated a “buy” rating and issued a $28.00 price target on shares of HilleVax in a report on Friday, May 10th. JPMorgan Chase & Co. lifted their price objective on HilleVax from $21.00 to $24.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 15th.

Hedge Funds Weigh In On HilleVax

Several institutional investors have recently modified their holdings of HLVX. Federated Hermes Inc. grew its position in shares of HilleVax by 80.6% during the 3rd quarter. Federated Hermes Inc. now owns 2,113 shares of the company’s stock worth $28,000 after buying an additional 943 shares during the period. EntryPoint Capital LLC acquired a new position in shares of HilleVax during the 1st quarter worth about $80,000. SG Americas Securities LLC acquired a new position in shares of HilleVax during the 4th quarter worth about $139,000. Seven Grand Managers LLC acquired a new position in shares of HilleVax during the 3rd quarter worth about $200,000. Finally, Tidal Investments LLC acquired a new position in shares of HilleVax during the 1st quarter worth about $207,000. 86.42% of the stock is currently owned by institutional investors and hedge funds.

HilleVax Company Profile

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.